Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Korzh Stanislava"

From Bioblast
Line 22: Line 22:


__TOC__
__TOC__


== Participated at ==
== Participated at ==
::::* [[MiPNet28.05 IOC158 Innsbruck AT|IOC158 Innsbruck AT]]
::::* [[FAT4BRAIN Workshop IOC151 Innsbruck AT]]
::::* [[FAT4BRAIN Workshop IOC151 Innsbruck AT]]
::::* [[FAT4BRAIN O2k-Workshop IOC148 Virtual Event]]
::::* [[FAT4BRAIN O2k-Workshop IOC148 Virtual Event]]


{{Labelingperson}}
{{Labelingperson}}

Revision as of 13:16, 14 March 2023

Name Korzh Stanislava, MSc.
Institution Latvian Institute of Organic Synthesis, LV
Address Aizkraukles Str 21, LV-1006
City Riga
State/Province
Country Latvia
Email [email protected]
Weblink
O2k-Network Lab LV Riga Liepins E



Participated at


Labels:



Publications

 PublishedReference
Al-Sabri 2024 Sci Rep2024Al-Sabri MH, Ammar N, Korzh S, Alsehli AM, Hosseini K, Fredriksson R, Mwinyi J, Williams MJ, Boukhatmi H, Schiรถth HB (2024) Fluvastatin-induced myofibrillar damage is associated with elevated ROS, and impaired fatty acid oxidation, and is preceded by mitochondrial morphological changes. https://doi.org/10.1038/s41598-024-53446-w
Cecatto 2023 MitoFit2023Cecatto C, Cardoso LHD, Ozola M, Korzh S, Zvejniece L, Gukalova B, Doerrier C, Dambrova M, Gnaiger E, Makrecka-Kuka M, Liepinsh E (2023) Fatty acid ฮฒ-oxidation in brain mitochondria: Insights from high-resolution respirometry in mouse, rat and Drosophila brain, ischemia and aging models. MitoFit Preprints 2023.10. https://doi.org/10.26124/mitofit:2023-0010
Makrecka-Kuka 2020 Cardiovasc Drugs Ther2020Makrecka-Kuka Marina, Korzh Stanislava, Videja Melita, Vilks Karlis, Cirule Helena, Kuka Janis, Dambrova Maija, Liepinsh Edgars (2020) Empagliflozin protects cardiac mitochondrial fatty acid metabolism in a mouse model of diet-induced lipid overload. Cardiovasc Drugs Ther 34:791-97.

Abstracts

Add abstract